Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aggressive Intravenous Hydration With Lactated Ringer's Solution Plus Rectal Indometacin Versus Rectal Indometacin Alone to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy: A Multicentre, Superiority, Randomised, Controlled Trial

NCT07202559 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT07202559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07202559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aggressive Intravenous Hydration With Lactated Ringer's Solution Plus Rectal Indometacin Versus Rectal Indometacin Alone to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy: A Multicentre, Superiority, Randomised, Controlled Trial
Lead sponsor
Changhai Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
October 13, 2025
Completion date
December 1, 2027
Enrollment
1,250 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic duct stones, pancreatitis, acute, pancreatitis, chronic